Business Description
OptiBiotix Health PLC
NAICS : 561499
ISIN : GB00BP0RTP38
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.92 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 13.58 | |||||
Beneish M-Score | -2.57 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -24.1 | |||||
3-Year FCF Growth Rate | -7.2 | |||||
3-Year Book Growth Rate | -10.2 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.67 | |||||
9-Day RSI | 46.45 | |||||
14-Day RSI | 42.17 | |||||
6-1 Month Momentum % | -4.55 | |||||
12-1 Month Momentum % | -45.69 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.18 | |||||
Quick Ratio | 5.36 | |||||
Cash Ratio | 4.04 | |||||
Days Inventory | 256.9 | |||||
Days Sales Outstanding | 300.21 | |||||
Days Payable | 362.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.2 | |||||
Shareholder Yield % | -10.49 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 47.98 | |||||
Operating Margin % | -351.67 | |||||
Net Margin % | -524.43 | |||||
FCF Margin % | -296.25 | |||||
ROE % | -35.39 | |||||
ROA % | -32.73 | |||||
ROIC % | -25.37 | |||||
3-Year ROIIC % | 14.76 | |||||
ROC (Joel Greenblatt) % | -565.57 | |||||
ROCE % | -26.75 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 20.83 | |||||
PB Ratio | 1.67 | |||||
Price-to-Tangible-Book | 2.14 | |||||
EV-to-EBIT | -4.76 | |||||
EV-to-EBITDA | -5.25 | |||||
EV-to-Forward-EBITDA | -41.14 | |||||
EV-to-Revenue | 19.67 | |||||
EV-to-Forward-Revenue | 4.97 | |||||
EV-to-FCF | -6.64 | |||||
Price-to-Net-Current-Asset-Value | 15 | |||||
Price-to-Net-Cash | 15 | |||||
Earnings Yield (Greenblatt) % | -21.01 | |||||
FCF Yield % | -13.77 |